Advisors

The Advisory Board is led by Dr. Howard Maibach. Dr. Maibach is the world’s preeminent expert regarding transdermal drug delivery, and author of countless books and publications regarding transdermal drug delivery.

Dr. Professor Georgios Imanidis

Dr. Professor Georgios Imanidis, Chief Science Officer. Dr. Imanidis is a leading expert on new drug delivery therapies and devices. He is the head of the PharmaCenter at the University of Basel. His research focuses on dermal, transdermal and cellular drug delivery and absorption. His emphasis is placed on delivery and transport mechanisms of drugs and model drug entities across biological, phospholipids bilayers and artificial membranes under special consideration of membrane properties, drug carriers, formulation design and time-dependent controlled drug delivery. Dr. Imanidis chairs the editorial board of the European Journal of Pharmaceutical Sciences, and is a member of the international advisory board of the International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2004. Dr. Imanidis is a valued consultant to the pharmaceutical industry on a project basis in the areas of transdermal drug delivery.

Michael D. Reed, Pharm.D., FCCP, FCP

Michael D. Reed, Pharm.D., FCCP, FCP, Dr. Reid is a world leading clinical pharmacologist and is author of countless books and publications regarding clinical pharmacology. He has a core expertise in chrono-pharmacology, and is a leading clinician for CNS disorders, addiction management and pain management pain management. He is currently the head of Clinical Pharmacology and Toxicology at Children’s Hospital Medical Center of Akron, and is a Professor, Department of Pediatrics, Division of Pediatric Pharmacology and Critical Care, Case Western Reserve University School of Medicine. He has conducted numerous clinical studies and is an active and sought out guest speaker in this field.

Robert Etheredge, PhD

Robert Etheredge, PhD., Dr. Etheredge has served the medical device and drug delivery industries for over 20 years, has published extensively, and holds numerous patents for medical innovations. Dr. Etheredge has personally managed all phases of medical device development from early phase needs identification and ideation to latter-phase manufacturing transition and post marketing surveillance. During the last decade, Dr. Etheredge was Principal Scientist and Partner at Arthur D. Little Inc. (now TIAX LLC).

Joseph Huang, PhD

Joseph Huang, PhD., Dr. Huang is a preeminent expert regarding micro fabrication, micro fluidics, and method development for drug delivery, molecular and biological detection and diagnostics, and medical devices. He has been a pioneer in the areas of biological and medical engineering, bioMEMS, bio-instrumentation, electronic design, and medical device for over 18 years. He has developed and patented cutting-edge technologies and holds tens key patents effective in a total of fourteen countries.

Dr. Diana Fu, MD

Dr. Diana Fu, MD. Dr. Fu is a leading expert on pharmacokinetics and P/K profiles for a wide range of therapeutic areas. She is a leading authority on Parkinson’s disease, Alzheimer’s Disease, pain management and depression. Dr. Fu is also a leading expert on neurological disorders and is one of the United Stated military’s top flight surgeons.

Ms. Carol Burton, Esq

Ms. Carol Burton, Esq. Ms. Burton is a leading patent attorney at the leading law firm of HOGAN and HARTSON LLP. Ms. Burton leads the patent team at her office. Her practice primarily involves obtaining U.S. patents for national and international medical device clients and maintaining their patent portfolios as well as supervising the firm's international patent prosecution practice. She is also extensively involved in counseling clients in the identification and protection of intellectual property assets. In addition to an active patent prosecution practice, Carol has provided key support in patent infringement cases.

Mr. Steven Boyko, Esq

Mr. Steven Boyko, Esq. Mr. Boyko is a leading Manhattan finance attorney in the leading firm of PROSKAUER ROSE LLP. He specializes in synthesizing and structuring complex financing transactions, joint ventures and mergers and acquisitions.